(Q50311636)

2 March 2018

title

Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. (English)

1 reference

2 March 2018

0 references

1 reference

Mark R Dadds

1

1 reference

2 March 2018

Elayne MacDonald

2

1 reference

2 March 2018

Avril Cauchi

3

1 reference

2 March 2018

Katrina Williams

4

1 reference

2 March 2018

Florence Levy

5

1 reference

2 March 2018

John Brennan

6

1 reference

2 March 2018

language of work or name

English

0 references

publication date

1 March 2014

1 reference

2 March 2018

Journal of Autism and Developmental Disorders

published in

1 reference

2 March 2018

volume

44

1 reference

2 March 2018

issue

3

1 reference

2 March 2018

page(s)

521-531

1 reference

2 March 2018

Abnormal processing of social information from faces in autism

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Varieties of repetitive behavior in autism: comparisons to mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

The origins of attachment theory: John Bowlby and Mary Ainsworth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Love, eye contact and the developmental origins of empathy v. psychopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Reduced eye gaze explains "fear blindness" in childhood psychopathic traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Sex differences in vasopressin and oxytocin innervation of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A screening questionnaire for Asperger syndrome and other high-functioning autism spectrum disorders in school age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin and autistic disorder: alterations in peptide forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Genomic and epigenetic evidence for oxytocin receptor deficiency in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin increases gaze to the eye region of human faces

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin increases retention of social cognition in autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A sniff of trust: meta-analysis of the effects of intranasal oxytocin administration on face recognition, trust to in-group, and trust to out-group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

The emergence of the social brain network: evidence from typical and atypical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin increases trust in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A comparison of two group-delivered social skills programs for young children with autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Neuropeptidergic regulation of affiliative behavior and social bonding in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A multisite study of the clinical diagnosis of different autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Plasma oxytocin levels in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Social skills interventions for individuals with autism: evaluation for evidence-based practices within a best evidence synthesis framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

The neurobiology of social recognition, approach, and avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-013-1899-3

A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions

21 January 2018

1 reference

12 December 2020

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

1 reference

12 December 2020

Social attention: a possible early indicator of efficacy in autism clinical trials

1 reference

12 December 2020

Infant intersubjectivity: research, theory, and clinical applications

1 reference

12 December 2020

Social effects of oxytocin in humans: context and person matter

1 reference

12 December 2020

Neural bases and development of face recognition in autism

1 reference

12 December 2020

10.1007/S10803-013-1899-3

Identifiers

DOI

1 reference

2 March 2018

1 reference

2 March 2018